Table 2.
Association between KIF4A and the clinicopathological characteristics of TNBC
| Variables | Cases (n = 240) | KIF4A | P value | |
|---|---|---|---|---|
| Low (n = 130) | High (n = 110) | |||
| Age (years) | 0.257 | |||
| < 50 | 136 | 78 (57.4%) | 58 (42.6%) | |
| ≥ 50 | 104 | 52 (50.0%) | 52 (50.0%) | |
| Menopause | 0.428 | |||
| no | 144 | 81 (56.3%) | 63 (43.8%) | |
| yes | 96 | 49 (51.0%) | 47 (49.0%) | |
| Tumor Size | 0.070 | |||
| ≤ 2.0 cm | 66 | 42 (63.6%) | 24 (36.4%) | |
| > 2.0 cm | 174 | 88 (50.6%) | 86 (49.4%) | |
| Lymph node Metastasis | <0.001* | |||
| No | 123 | 81 (65.9%) | 42 (34.1%) | |
| Yes | 117 | 49 (41.9%) | 68 (58.1%) | |
| TNM Stage | <0.001* | |||
| I-II | 187 | 113 (60.4%) | 74 (39.6%) | |
| III-IV | 53 | 17 (32.1%) | 36 (67.9%) | |
*P < 0.05, statistically significant